China NMPA Product Recall - Liquid dressing

Guangzhou Beogene Biotechnology Co., Ltd. initiated a voluntary Class III recall of its liquid dressings (production batch number 2021070801) on April 19, 2022. This action was prompted by consumer feedback reporting the presence of black impurities within one box of the product. The affected liquid dressings, registered under 粤穗械备20200263号, are subject to this recall to ensure product safety and quality.

The recall event is being managed in accordance with the regulatory framework set forth by the National Medical Products Administration (NMPA) and the Guangdong Provincial Drug Administration, utilizing a standard "Medical Device Recall Event Report Form." A Class III recall typically signifies a situation where the use of or exposure to a violative product is not likely to cause adverse health consequences, but corrective action is still necessary to address product deficiencies.

Guangzhou Beogene Biotechnology Co., Ltd.'s decision to conduct a voluntary recall underscores their commitment to addressing product quality concerns proactively. The company is taking steps to withdraw the specified batch from distribution channels and investigate the root cause of the impurity issue, aiming to prevent recurrence and maintain consumer trust. This measure ensures that product integrity is upheld and potential risks, however minor, are mitigated effectively under the oversight of relevant regulatory bodies.